Furthermore, in the Versteeg dataset, high mRNA levels of HIF1A and EPAS1 were still significantly associated with lower overall survival and relapse-free survival in the sub-set of patients with advanced-stage tumor (i.e., stage 4) (Supplementary Data, Fig. S1). This evidence concerns the gene HIF1A and neoplasm.